Key result
In patients with mitral annulus calcification undergoing surgery, 5-year survival was higher in those with Barlow disease compared to fibroelastic deficiency.
Why the study?
Does the underlying etiology (Barlow disease vs fibroelastic deficiency) affect repair feasibility and surgical outcomes in patients with mitral annulus calcification?
Cohort (n=124)
Does the underlying etiology (Barlow disease vs fibroelastic deficiency) affect repair feasibility and surgical outcomes in patients with mitral annulus calcification?
In patients with mitral annulus calcification, the underlying etiology (Barlow disease vs fibroelastic deficiency) strongly determines the feasibility of valve repair and long-term survival.
Answers are grounded in this paper and cite their sources.
Etiology may influence survival after mitral annulus calcification surgery and should not yet change practice; leaves open effects on repair feasibility.
OBJECTIVE: The aim of this study was to determine the factors influencing the feasibility of valve repair and the surgical outcome in patients with mitral annulus calcification. METHODS: In 124 patients with mitral annulus calcification undergoing surgery, two entities were distinguished: Barlow disease (myxomatous leaflets, n=60) and fibroelastic deficiency (FED) (normal leaflets, n=64). The calcification score was lower (1.9 vs 2.8); the annulus was more dilated (ring 35 vs 32 mm) and ruptured chordae were more frequent (77% vs 37%) in Barlow than in FED (p<0.001). The clinical profile was different: age (60+/-14 vs 73+/-8 years, p<0.001), systemic hypertension (22% vs 70%, p<0.001), chronic renal insufficiency (5% vs 22%, p<0.01), cancer (7% vs 25%, p<0.01). Multifocal atherosclerosis was less frequent in Barlow than in FED: carotid disease (17% vs 54%, p<0.001), aortic atheroma (21% vs 51%, p<0.001) and coronary disease (22% vs 56%, p<0.01). Echocardiography showed two different patterns in Barlow and FED: aortic valve stenosis (1.7% vs 31%), left atrial diameter (54 vs 49 mm), left ventricular end-diastolic diameter (62 vs 54 mm), interventricular septal thickness (11 vs 13 mm), and systolic pulmonary pressure (40 vs 56 mmHg), respectively (p<0.001). Bacterial endocarditis was observed in 24 cases (19%). RESULTS: The surgical technique was a valve repair in 68% and a replacement in 32%. The repair rate depended upon the extent of annulus calcifications (p<0.001) and the type of degenerative disease (95% vs 44% in Barlow and FED p<0.001). In-hospital mortality was 14% (Barlow: 5% vs FED: 23%, p<0.01). The mean follow-up was 50+/-41 months. Overall 5-year year survival was 76% (Barlow: 90% vs FED: 64%, p<0.001) and survival free from cardiac event was 69% at 5 years (Barlow: 87% vs FED: 52%, p<0.001). Five-year survival was higher following repair than replacement (84% vs 64% p<0.001). Chronic renal insufficiency and bacterial endocarditis were two predictors of early and late death (p<0.01). CONCLUSIONS: The aetiopathogeny of the degenerative mitral disease responsible for annulus calcifications corresponded to distinct anatomical, clinical and echographic patterns. It was a main determinant of repair feasibility, early and late surgical outcome.
No takes yet. Share an insight, caveat, or question.
D’Alessandro et al. (2007) conducted a cohort in Mitral annulus calcification (n=124). Barlow disease vs. Fibroelastic deficiency (FED) was evaluated on 5-year survival (p=<0.001). In patients with mitral annulus calcification undergoing surgery, 5-year survival was higher in those with Barlow disease compared to fibroelastic deficiency.
Synapse has enriched 10 related papers. Consider them for comparative context: